ACP^®215 Automated Cell Processor

• ACP 215 brochure View document

• U.S. DoD deploys blood units worldwide with the ACP 215 system View document

The ACP 215 is intended to glycerolize and deglycerolize red blood cells derived from whole blood that have been stored in any approved anticoagulant/additive solution for up to 6 days at 1-6°C prior to glycerolization.

Red blood cells, derived from whole blood collections and non-leukoreduced, that have been collected and stored in CPDA-1, glycerolized using the ACP 215 and frozen at -80°C, and deglycerolized using the ACP 215 and stored in Haemonetics AS-3 at 1-6°C may be labeled for extended storage for 14 days.

In addition, red blood cells that have been collected and stored in CPD/AS-1 or CP2D/AS-3, leukoreduced, glycerolized using the ACP 215, frozen at -65°C or colder, deglycerolized by the ACP 215, and stored in Haemonetics AS-3 at 1-6°C maybe be labeled for extended storage for 14 days.

Red blood cells collected in any other anticoagulant/additive solution will be labeled with a 24-hour outdate.

Red cells, non-leukoreduced, that were manually glycerolized using the 50% W/V glycerol (Valeri Method) and frozen at -65°C or colder may be deglycerolized using the ACP 215 and labeled with a 24 hour outdate.

Please refer to the manual for indications for use, contraindications, warnings, precautions and potential adverse events.